Lipum AB engages in the research and development of novel anti-inflammatory drugs. It focuses in chronic inflammatory diseases. The company was founded by Olle Carl Hernell, Lennart Gustav Lundberg, and Susanne Eva Lindquist on June 17, 2010 and is headquartered in Umea, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company